Breaking News
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Heart attacks more likely to be fatal in women and rates are rising
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
Study reveals how one mutation causes the most common inherited intellectual disability

Study reveals how one mutation causes the most common inherited intellectual disability

image_pdfDownload PDFimage_print

Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.

“Fragile X syndrome has been studied as a model of intellectual disability because in theory it’s comparatively simple,” says senior author Xinyu Zhao, a professor of neuroscience in the Waisman Center at the University of Wisconsin-Madison.

Fragile X patients have difficulty in learning and language, as well as temper tantrums, hyperactivity and extreme sensitivity to light and sound. The fragile X gene is located on the X chromosome and its mutation affects about 1 in 4,000 boys and 1 in 7,000 girls.

Nearly half of fragile X patients are also diagnosed with autism.

Zhao’s new study, in the journal Nature Neuroscience, shows that when mutated, the fragile X gene fails to produce its unique protein. As a result, subcellular units called mitochondria inside developing neurons are malformed, so the neuron is unable to create the necessary network of branches and contacts it needs to communicate.

These mechanisms link the fragile X mutation to the profound intellectual deficits in fragile X syndrome, Zhao says.

By blocking the proper formation and function of mitochondria, the fragile X mutation may also play a role in several other conditions. About 2 to 3 percent of people with autism have fragile X syndrome. “Autism is linked to more than 1,000 genes,” she says. “Because the fragile X gene is linked to more cases of autism than any other gene, what we have learned from fragile X helps us to understand autism.”

Despite the strong overlap, “until now, we did not know why this mutated gene causes either condition,” Zhao says.

Mitochondria have long been known as a cell’s powerhouse, but their other roles in brain development are only gradually becoming clear. Healthy mitochondria allow neurons to create more energy and have greater electrical activity. Mitochondria also support the establishment of dendrites, axons and synapses, parts of the elaborate linkages that allow brain cells to communicate with each other.

“Although mitochondria play a role in many diseases,” Zhao says, “this is the first time mitochondria dysfunction has been directly implicated in fragile X syndrome.”

Minjie Shen, lead author and a postdoctoral fellow in Zhao’s group, also transplanted immature, human neurons into mouse brains. Because these cells were grown from cells donated by fragile X patients, they carried the fragile X mutation. In these mice, low levels of the fragile X protein, FMRP, were associated with high levels of damaging oxidative stress caused by a variety of oxygen-bearing molecules.

“This is the first time that human fragile X neurons have been studied in any living brain,” Zhao says. “And so this information is more relevant to human neural development than what we can see in lab dishes.”

In a compelling demonstration of mitochondria’s role in fragile X symptoms, Zhao’s research group used a chemical that promotes mitochondria formation to reverse behaviors like hyperactivity and impaired social interaction in these mice.

The fragile X gene gains its power because it is a “regulator gene” that controls the action of dozens, even hundreds, of “downstream genes.” Indeed, the fragile X protein affects about 4 percent of messenger RNAs — compounds that “read” the genetic template of DNA to pattern new proteins.

The central finding of the new study, Zhao says, “is that we have discovered the first convincing mechanism that could explain the neurological impairment in fragile X, and that mechanism is defective mitochondria.”

Other developmental disorders, including Huntington’s disease, Rett syndrome and Down syndrome, seem to feature mitochondria dysfunction as well, she notes.

After a neuron distinguishes itself from its parent cells, the hundreds or thousands of mitochondria within engage in an elaborate dance, joining and separating in a dynamic balance that is vital to many biological functions. But with the fragile X mutation, “we see that the mitochondria are more fragmented, shorter and round rather than long and tubular, due either to decreased fusion or increased fission,” Zhao says.

The result is a neuron with impaired connectivity and less resistance to destructive oxidant chemicals.

“When we restored mitochondria fusion with gene editing or a chemical compound, we partly restored neuronal development,” Zhao says. “In mice lacking FMRP, we also rescued some behavioral deficits using the chemical treatment.

“This is the first direct evidence that mitochondrial dysfunction contributes to pathogenesis of fragile X,” she adds, “and I hope it will open new investigations and new therapeutic developments.”

Pinpointing a mechanism for fragile X is a first step to finding chemicals that might block or reverse that mechanism, Zhao says. Any treatment that is developed for these defects could be used after birth, during the period when neurons start to mature, Zhao says.

Although such a potential treatment is years away, the current study is a major advance for conditions that today lack treatments, Zhao says. “Human neuroscience seems to get more complex all the time, but I feel we’ve established a foothold that allows us to see the true source of difficulty in several serious neurological disorders. And that’s exactly our role as basic neuroscientists.”

Tagged with:

About author

Related Articles